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Background
The high metabolic activity of the heart makes it particu-
larly suited to the use of hyperpolarized (HP) 13C meth-
ods to non-invasively detect and characterize metabolic
changes that occur during ischemia/reperfusion (I/R).
Energy metabolism in ischemic rat hearts has been pre-
viously interrogated with HP 13C-labelled pyruvate ex
vivo, and its hyperpolarized metabolites have been imaged
in the ischemic pig heart in vivo. In both cases, a decrease
in the conversion to labelled bicarbonate was observed vs.
conversion to lactate, consistent with the expected
decrease in pyruvate oxidation. Here, our aim was to
establish this I/R model in rats and to correlate metabolic
changes with the area at risk.
Methods
The femoral arteries and a vein were catheterized in
anaesthetized, intubated Wistar rats (n=16, 265.9 ± 3.1 g).
After positioning the rat in the MR scanner (Varian, 9.4T)
and shimming, a solution of HP [1-13C]pyruvate was
infused. A series of 40 single pulse (300 flip angle) 13C
MR spectra was then acquired (gated by pulse and respira-
tion, TR ~3s) using a surface coil over the heart, to estab-
lish the baseline state. Myocardial ischemia was effected
by occlusion with a snare installed around the left coron-
ary artery, in place for 15 min (omitted in controls), fol-
lowed by another HP infusion and spectral acquisition. To
determine the size of area at risk, the heart was stained
with Evans blue. Spectral peaks were quantified by fitting,
and areas under curve (AUC) for metabolite signal time
courses were calculated using the spectral signal amplitude
and the time between gated acquisitions. Statistical signifi-
cance was calculated by one-way ANOVA.
Results
The HP metabolites [1-13C]lactate, [1-13C]alanine and
13C-bicarbonate were detected before and after myocar-
dial ischemia. The 13C-bicarbonate-to-[1-13C]lactate
(Bic-to-Lac) ratio was 0.68 ± 0.03 SEM the level of base-
line (n=3), compared to 1.11 ± 0.10 in control experi-
ments (n=5) (p=0.02), reflecting the shift from oxidative
metabolism to anaerobic metabolism. (Figure 1) To
reduce the mortality rate, another set of experiments
was performed with the occluding thread placed more
distally on the coronary artery; this resulted in a similar
decrease in the Bic-to-Lac ratio, 0.75 ± 0.07 compared
to baseline (n=8) (p=0.01 vs. control). The variability in
the metabolic perturbation of the latter group was com-
pared to the size of the area at risk, which ranged from
4.4 to 47.5% of the heart, (Figure 2) and shows a trend
towards a greater metabolic change with a larger area at
risk, but with significant variability.
Conclusions
This study demonstrates the feasibility of using HP 13C
MRS to detect metabolic changes in rat myocardial
metabolism in vivo after a brief ischemic episode and
suggests the possibility of spectroscopically estimating
the extent of injury. It provides a platform to investigate
future treatment strategies to reduce reperfusion injury.
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Figure 1 Change in hyperpolarized 13C-bicarbonate-to-[1-13C]lactate
ratio following 15 min period of ischemia, compared to baseline. In
control experiments, bic-to-lac ratio is near baseline level. After
ischemia, the ratio is significantly lower. Occluding higher on LAD
results in large area at risk, while occluding lower results in a more
variable area at risk and variable metabolic change.
Figure 2 Change in hyperpolarized 13C-bicarbonate-to-[1-13C]
lactate ratio following 15 min period of ischemia with occluding
thread placed lower on LAD, compared to size of area at risk
measured by Evans blue staining. Solid line shows linear regression
with 95% confidence interval in dotted lines.
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